Head to Head Analysis: USANA Health Sciences (USNA) vs. Perrigo Company (PRGO)

USANA Health Sciences (NYSE: USNA) and Perrigo Company (NYSE:PRGO) are both non-cyclical consumer goods & services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitabiliy, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for USANA Health Sciences and Perrigo Company, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences 0 1 1 0 2.50
Perrigo Company 2 8 5 0 2.20

USANA Health Sciences presently has a consensus price target of $112.50, indicating a potential upside of 76.47%. Perrigo Company has a consensus price target of $81.85, indicating a potential upside of 13.11%. Given USANA Health Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe USANA Health Sciences is more favorable than Perrigo Company.


This table compares USANA Health Sciences and Perrigo Company’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
USANA Health Sciences 8.37% 25.23% 18.18%
Perrigo Company -43.81% 11.79% 5.43%

Risk & Volatility

USANA Health Sciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Perrigo Company has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.


Perrigo Company pays an annual dividend of $0.64 per share and has a dividend yield of 0.9%. USANA Health Sciences does not pay a dividend. Perrigo Company pays out -3.9% of its earnings in the form of a dividend. USANA Health Sciences has raised its dividend for 14 consecutive years.

Insider & Institutional Ownership

44.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 76.5% of Perrigo Company shares are held by institutional investors. 53.2% of USANA Health Sciences shares are held by insiders. Comparatively, 6.9% of Perrigo Company shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares USANA Health Sciences and Perrigo Company’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
USANA Health Sciences $1.02 billion 1.53 $151.43 million $3.97 16.08
Perrigo Company $5.13 billion 2.02 $1.12 billion ($16.39) -4.41

Perrigo Company has higher revenue and earnings than USANA Health Sciences. Perrigo Company is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.


USANA Health Sciences beats Perrigo Company on 9 of the 16 factors compared between the two stocks.

About USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

About Perrigo Company

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply